These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22125075)

  • 1. Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes.
    Delgoffe GM; Powell JD
    Methods Mol Biol; 2012; 821():317-27. PubMed ID: 22125075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mTOR pathway and integrating immune regulation.
    Cobbold SP
    Immunology; 2013 Dec; 140(4):391-8. PubMed ID: 23952610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR signaling in the differentiation and function of regulatory and effector T cells.
    Zeng H; Chi H
    Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.
    Ye L; Lee J; Xu L; Mohammed AU; Li W; Hale JS; Tan WG; Wu T; Davis CW; Ahmed R; Araki K
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27974559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for mammalian target of rapamycin in regulating T cell activation versus anergy.
    Zheng Y; Collins SL; Lutz MA; Allen AN; Kole TP; Zarek PE; Powell JD
    J Immunol; 2007 Feb; 178(4):2163-70. PubMed ID: 17277121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.
    Marcais A; Blevins R; Graumann J; Feytout A; Dharmalingam G; Carroll T; Amado IF; Bruno L; Lee K; Walzer T; Mann M; Freitas AA; Boothby M; Fisher AG; Merkenschlager M
    J Exp Med; 2014 Oct; 211(11):2281-95. PubMed ID: 25311506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.
    Chen G; Dong Z; Liu H; Liu Y; Duan S; Liu Y; Liu F; Chen H
    J Immunol; 2016 Nov; 197(10):3917-3926. PubMed ID: 27798166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.
    Delgoffe GM; Pollizzi KN; Waickman AT; Heikamp E; Meyers DJ; Horton MR; Xiao B; Worley PF; Powell JD
    Nat Immunol; 2011 Apr; 12(4):295-303. PubMed ID: 21358638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of T cells by mTOR: the known knowns and the known unknowns.
    Pollizzi KN; Powell JD
    Trends Immunol; 2015 Jan; 36(1):13-20. PubMed ID: 25522665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.
    Hurez V; Dao V; Liu A; Pandeswara S; Gelfond J; Sun L; Bergman M; Orihuela CJ; Galvan V; Padrón Á; Drerup J; Liu Y; Hasty P; Sharp ZD; Curiel TJ
    Aging Cell; 2015 Dec; 14(6):945-56. PubMed ID: 26315673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Signaling pathway as a master regulator of memory CD8
    Rostamzadeh D; Yousefi M; Haghshenas MR; Ahmadi M; Dolati S; Babaloo Z
    J Cell Physiol; 2019 Aug; 234(8):12353-12368. PubMed ID: 30710341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
    Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
    J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
    Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
    Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T follicular helper and memory cell responses and the mTOR pathway in murine heart transplantation.
    Xie A; Yan H; Fu J; He A; Xiao X; Li XC; Chen W
    J Heart Lung Transplant; 2020 Feb; 39(2):134-144. PubMed ID: 31831210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR regulates T-cell differentiation and activation in immunity and autoimmunity.
    Bi Y; Liu G; Yang R
    Crit Rev Eukaryot Gene Expr; 2011; 21(4):313-22. PubMed ID: 22181701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of mTOR on T helper cell differentiation and dendritic cell function.
    Salmond RJ; Zamoyska R
    Eur J Immunol; 2011 Aug; 41(8):2137-41. PubMed ID: 21725971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway.
    Zhao YG; Wang Y; Guo Z; Gu AD; Dan HC; Baldwin AS; Hao W; Wan YY
    J Immunol; 2012 Nov; 189(9):4417-25. PubMed ID: 22993204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roquin Suppresses the PI3K-mTOR Signaling Pathway to Inhibit T Helper Cell Differentiation and Conversion of Treg to Tfr Cells.
    Essig K; Hu D; Guimaraes JC; Alterauge D; Edelmann S; Raj T; Kranich J; Behrens G; Heiseke A; Floess S; Klein J; Maiser A; Marschall S; Hrabĕ de Angelis M; Leonhardt H; Calkhoven CF; Noessner E; Brocker T; Huehn J; Krug AB; Zavolan M; Baumjohann D; Heissmeyer V
    Immunity; 2017 Dec; 47(6):1067-1082.e12. PubMed ID: 29246441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.